Universitätsmedizin der Johannes Gutenberg-Universität Mainz

S3 guidelines: Epicutaneous patch testing with contact allergens and drugs – Short version, Part 1 (2019) Mahler V, Nast A, Bauer A, Becker D, Brasch J, Breuer K, Dickel H, et al. Journal article S3-Leitlinie: Durchführung des Epikutantests mit Kontaktallergenen und Arzneimitteln – Kurzfassung Teil 1 (2019) Mahler V, Nast A, Bauer A, Becker D, Brasch J, Breuer K, Dickel H, et al. Journal article THE NOX1/4 INHIBITOR GKT831 ACHIEVES CLINICALLY MEANINGFUL REDUCTIONS IN LIVER STIFFNESS, ATTENUATES CHOLESTASIS, AND IMPROVES QUALITY OF LIFE IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (2019) Huang JC, Invernizzi P, Dalekos GN, Nevens F, Van Vlierberghe H, Zigmond E, Andrade RJ, et al. Conference contribution Optimal Vessel Sizing for the Bioresorbable Scaffold Implantation and the Incidence of Scaffold Thrombosis: Insights From the COMPARE-ABSORB Trial (2019) Chang CC, Onuma Y, Chevalier B, West N, Gori T, Barbato E, Tarantini G, et al. Conference contribution Bioresorbable Scaffold Versus Metallic Drug-Eluting Stent in Patients at High Risk of Restenosis (COMPARE-ABSORB trial): Very Late Device Thrombosis While on Extended DAPT (2019) Van Geuns RJ, Chang CC, Chevalier B, Gori T, Barbato E, Tarantini G, Achenbach S, et al. Conference contribution S2k-Leitlinie zur Therapie der Psoriasis bei Kindern und Jugendlichen - Kurzfassung Teil 2. (2019) Eisert L, Augustin M, Bach S, Dittmann M, Eiler R, Fölster-Holst R, Gerdes S, et al. Journal article Tumor immunoevasion by high glycolytic tumors through an acidosis-dependent induction of noninflammatory tumor-associated macrophages (2019) Bohn T, Rapp S, Pektor S, Gerlach K, Weigmann B, Lueckel C, Truong N, et al. Conference contribution Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine (2019) Schlenk RF, Weber D, Herr W, Wulf G, Salih HR, Derigs HG, Kuendgen A, et al. Journal article Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution